|
1
|
Chen J, Chen J, Wu X, Shi T and Kang M:
Efficacy of targeted agents in the treatment of elderly patients
with advanced non-small-cell lung cancer: A systematic review and
meta-analysis. OncoTargets Ther. 9:4797–4803. 2016. View Article : Google Scholar
|
|
2
|
Yano M, Yoshida J, Koike T, Kameyama K,
Shimamoto A, Nishio W, Yoshimoto K, Utsumi T, Shiina T, Watanabe A,
et al: The outcomes of a limited resection for non-small cell lung
cancer based on differences in pathology. World J Surg.
40:2688–2697. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Giopanou I, Lilis I, Papaleonidopoulos V,
Marazioti A, Spella M, Vreka M, Papadaki H and Stathopoulos GT:
Comprehensive evaluation of nuclear factor-κ β expression patterns
in non-small cell lung cancer. PloS One. 10:e01325272015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Arrieta O, Carmona A, Ramirez-Tirado LA,
Flores-Estrada D, Macedo-Pérez EO, Martínez-Hernández JN,
Corona-Cruz JF, Cardona AF and de la Garza J: Survival of patients
with advanced non-small cell lung cancer enrolled in clinical
trials. Oncology. 91:185–193. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fernandez-Lopez C, Exposito-Hernandez J,
Arrebola-Moreno JP, Calleja-Hernández MÁ, Expósito-Ruíz M,
Guerrero-Tejada R, Linares I and Cabeza-Barrera J: Trends in phase
III randomized controlled clinical trials on the treatment of
advanced non-small-cell lung cancer. Cancer Med. 5:2190–2197. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Paleiron N, Bylicki O, Andre M, Rivière E,
Grassin F, Robinet G and Chouaïd C: Targeted therapy for localized
non-small-cell lung cancer: A review. OncoTargets Ther.
9:4099–4104. 2016. View Article : Google Scholar
|
|
7
|
Aridgides P and Bogart J: Stereotactic
body radiation therapy for stage i non-small cell lung cancer.
Thoracic Surg Clin. 26:261–269. 2016. View Article : Google Scholar
|
|
8
|
Jiang J, Liang X, Zhou X, Huang R and Chu
Z: A meta-analysis of randomized controlled trials comparing
carboplatin-based to cisplatin-based chemotherapy in advanced
non-small cell lung cancer. Lung Cancer. 57:348–358. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
D'Addario G, Pintilie M, Leighl NB, Feld
R, Cerny T and Shepherd FA: Platinum-based versus
non-platinum-based chemotherapy in advanced non-small-cell lung
cancer: A meta-analysis of the published literature. J Clin Oncol.
23:2926–2936. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Forsythe B and Faulkner K: Overview of the
tolerability of gefitinib (IRESSA) monotherapy: Clinical experience
in non-small-cell lung cancer. Drug Saf. 27:1081–1092. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wong AM, Zhang Y, Kesler K, Deng M,
Burhenn L, Wang D, Moro A, Li Z and Heber D: Genomic and in vivo
evidence of synergy of a herbal extract compared to its most active
ingredient: Rabdosia rubescens vs. oridonin. Exp Ther Med.
1:1013–1017. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu QX, Yuan SX, Ren CM, Yu Y, Sun WJ, He
BC and Wu K: Oridonin upregulates PTEN through activating p38 MAPK
and inhibits proliferation in human colon cancer cells. Oncol Rep.
35:3341–3348. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shi M, Lu XJ, Zhang J, Diao H, Li G, Xu L,
Wang T, Wei J, Meng W, Ma JL, et al: Oridonin, a novel lysine
acetyltransferases inhibitor, inhibits proliferation and induces
apoptosis in gastric cancer cells through p53- and
caspase-3-mediated mechanisms. Oncotarget. 7:22623–22631.
2016.PubMed/NCBI
|
|
14
|
Ming M, Sun FY, Zhang WT and Liu JK:
Therapeutic effect of oridonin on mice with prostate cancer. Asian
Pac J Trop Med. 9:184–187. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kang N, Cao SJ, Zhou Y, He H, Tashiro S,
Onodera S, Qiu F and Ikejima T: Inhibition of caspase-9 by
oridonin, a diterpenoid isolated from Rabdosia rubescens, augments
apoptosis in human laryngeal cancer cells. Int J Oncol.
47:2045–2056. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang YY, Lv YF, Lu L and Cai L: Oridonin
inhibits mTOR signaling and the growth of lung cancer tumors.
AntiCancer Drugs. 25:1192–1200. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang S, Zhong Z, Wan J, Tan W, Wu G, Chen
M and Wang Y: Oridonin induces apoptosis, inhibits migration and
invasion on highly-metastatic human breast cancer cells. Am J Chin
Med. 41:177–196. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bao R, Shu Y, Wu X, Weng H, Ding Q, Cao Y,
Li M, Mu J, Wu W, Ding Q, et al: Oridonin induces apoptosis and
cell cycle arrest of gallbladder cancer cells via the mitochondrial
pathway. BMC Cancer. 14:2172014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Murayama C, Nagao Y, Sano S, Ochiai M,
Fuji K, Fujita E and Mori T: Effect of oridonin, a Rabdosia
diterpenoid, on radiosensitization with misonidazole. Experientia.
43:1221–1223. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sagar SM: Can the therapeutic gain of
radiotherapy be increased by concurrent administration of Asian
botanicals? Integr Cancer Ther. 9:5–13. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nishitani H, Sugimoto N, Roukos V,
Nakanishi Y, Saijo M, Obuse C, Tsurimoto T, Nakayama KI, Nakayama
K, Fujita M, et al: Two E3 ubiquitin ligases, SCF-Skp2 and
DDB1-Cul4, target human Cdt1 for proteolysis. EMBO J. 25:1126–1136.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Peng L, Xu Z, Zhou Y, Yang T, Liang ZQ and
Zhang M: Effect of rosiglitazone on cells cycle, apoptosis and
expression of Skp2 and p27Kip1 in hepatocellular carcinoma cell
line. Zhonghua Gan Zang Bing Za Zhi. 18:148–149. 2010.(In Chinese).
PubMed/NCBI
|
|
23
|
Schulman BA, Carrano AC, Jeffrey PD, Bowen
Z, Kinnucan ER, Finnin MS, Elledge SJ, Harper JW, Pagano M and
Pavletich NP: Insights into SCF ubiquitin ligases from the
structure of the Skp1-Skp2 complex. Nature. 408:381–386. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li Y, Wang Y, Wang S, Gao Y, Zhang X and
Lu C: Oridonin phosphate-induced autophagy effectively enhances
cell apoptosis of human breast cancer cells. Med Oncol. 32:3652015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shen H, Cao Y, Li X, Tan Y, Chen J, Yang
Z, Kong Y and Yuan Y: Surgical intervention improves survival for
metastatic non-small cell lung cancer patients. Medicine
(Baltimore). 95:e38002016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Santarpia M, Rolfo C, Peters GJ, Leon LG
and Giovannetti E: On the pharmacogenetics of non-small cell lung
cancer treatment. Expert Opin Drug Metab Toxicol. 12:307–317. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ohtaki Y, Shimizu K, Kaira K, Nagashima T,
Obayashi K, Nakazawa S, Kakegawa S, Igai H, Kamiyoshihara M,
Nishiyama M and Takeyoshi I: Risk factors associated with
recurrence of surgically resected node-positive non-small cell lung
cancer. Surg Today. 46:1196–1208. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang XH, Liu YX, Jia M, Han JS, Zhao M,
Ji SP and Li AM: Oridonin inhibits tumor growth in glioma by
inducing cell cycle arrest and apoptosis. Cell Mol Biol
(Noisy-le-grand). 60:29–36. 2014.PubMed/NCBI
|
|
29
|
Xu B, Shen W, Liu X, Zhang T, Ren J, Fan Y
and Xu J: Oridonin inhibits BxPC-3 cell growth through cell
apoptosis. Acta Biochim Biophys Sin (Shanghai). 47:164–173. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dong Y, Zheng Y, Xiao J, Zhu C and Zhao M:
Regulatory effect of Bcl-2 in ultraviolet radiation-induced
apoptosis of the mouse crystalline lens. Exp Ther Med. 11:973–977.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhen L, Li J, Zhang M and Yang K: MiR-10b
decreases sensitivity of glioblastoma cells to radiation by
targeting AKT. J Biol Res (Thessalon). 23:142016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu Q, Si T, Xu X, Liang F, Wang L and Pan
S: Electromagnetic radiation at 900 MHz induces sperm apoptosis
through bcl-2, bax and caspase-3 signaling pathways in rats. Reprod
Health. 12:652015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mendes F, Sales T, Domingues C, Schugk S,
Abrantes AM, Gonçalves AC, Teixo R, Silva R, Casalta-Lopes J, Rocha
C, et al: Effects of X-radiation on lung cancer cells: The
interplay between oxidative stress and P53 levels. Med Oncol.
32:2662015. View Article : Google Scholar : PubMed/NCBI
|
